Rezultati - Jenny E. Blau
- Showing 1 - 10 results of 10
-
1
Adverse effects of SGLT2 inhibitors on bone health od Jenny E. Blau, Simeon I. Taylor
Izdano 2018Revisão -
2
SGLT2 Inhibitors May Predispose to Ketoacidosis od Simeon I. Taylor, Jenny E. Blau, Kristina I. Rother
Izdano 2015Revisão -
3
Possible adverse effects of SGLT2 inhibitors on bone od Simeon I. Taylor, Jenny E. Blau, Kristina I. Rother
Izdano 2014Artigo -
4
-
5
-
6
-
7
-
8
Canagliflozin triggers the FGF23/1,25-dihydroxyvitamin D/PTH axis in healthy volunteers in a randomized crossover study od Jenny E. Blau, Viviana Bauman, Ellen M. Conway, Paolo Piaggi, Mary Walter, Elizabeth C. Wright, Shanna Bernstein, Amber B. Courville, Michael T. Collins, Kristina I. Rother, Simeon I. Taylor
Izdano 2018Artigo -
9
The greater impact of <scp><i>PNPLA3</i></scp> polymorphism on liver‐related events in Japanese non‐alcoholic fatty liver disease patients: A multicentre cohort study od Yuya Seko, Kanji Yamaguchi, Toshihide Shima, Michihiro Iwaki, Hirokazu Takahashi, Miwa Kawanaka, Saiyu Tanaka, Yasuhide Mitsumoto, Masato Yoneda, Atsushi Nakajima, Ola Fjellström, Jenny E. Blau, Björn Carlsson, Takeshi Okanoue, Yoshito Itoh
Izdano 2023Artigo -
10
Genotype-phenotype correlation in multiple endocrine neoplasia type 1 od CHARLITA WORTHY, Rana Tora, Chandra N. Uttarkar, James Welch, Lynn S. Bliss, Craig Cochran, Anisha Ninan, Sheila Kumar, Stephen A. Wank, Sungyoung Auh, Lee S. Weinstein, William F. Simonds, Sunita Agarwal, Jenny E. Blau, Smita Jha
Izdano 2025Artigo
Iskalna orodja:
Sorodne teme
Internal medicine
Medicine
Diabetes mellitus
Endocrinology
Type 2 diabetes
Adverse effect
Canagliflozin
Dapagliflozin
Insulin
Chemistry
Diabetic ketoacidosis
Intensive care medicine
Ketoacidosis
Pharmacology
Type 1 diabetes
Alternative medicine
Biochemistry
Biology
Calcium
Empagliflozin
Food science
Gene
Genetics
Genotype
Parathyroid hormone
Pathology
Placebo
Acidosis
Adverse Event Reporting System
Alcoholic liver disease